Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Cyclobenzaprine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for cyclobenzaprine hydrochloride and what is the scope of cyclobenzaprine hydrochloride patent protection?

Cyclobenzaprine hydrochloride
is the generic ingredient in three branded drugs marketed by Oxford Pharms, Actavis Labs Fl Inc, Orit Labs Llc, Pliva, Janssen Res And Dev, Sun Pharm Inds Ltd, Watson Labs, Frontida Biopharm, Aurobindo Pharma, Mylan Pharms Inc, Kvk Tech, Upsher-smith Labs, Jubilant Cadista, Teva Pharms Intl, Invagen Pharms, Twi Pharms Inc, Sandoz, and Prinston Inc, and is included in twenty NDAs. There are eight patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Cyclobenzaprine hydrochloride has one patent family member in one country.

There are fifteen drug master file entries for cyclobenzaprine hydrochloride. Seventy-four suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: cyclobenzaprine hydrochloride

Tradenames:3
Patents:8
Applicants:18
NDAs:20
Drug Master File Entries: see list15
Suppliers / Packagers: see list74
Bulk Api Vendors: see list50
Clinical Trials: see list996
Patent Applications: see list1,049
Therapeutic Class:Skeletal Muscle Relaxants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cyclobenzaprine hydrochloride at DailyMed

Pharmacology for Ingredient: cyclobenzaprine hydrochloride

Tentative approvals for CYCLOBENZAPRINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe15MGCAPSULE, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe30MGCAPSULE, EXTENDED RELEASE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL078722-003May 12, 2008ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL078643-001Sep 26, 2008ABRXNoNo► Subscribe► Subscribe
Prinston Inc
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL077797-002Feb 28, 2007ABRXNoNo► Subscribe► Subscribe
Teva Pharms Intl
AMRIX
cyclobenzaprine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021777-002Feb 1, 2007RXYesYes7,829,121► Subscribe ► Subscribe
Orit Labs Llc
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride
TABLET;ORAL078218-001Apr 18, 2008ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot